On Sept. 8, 2020, the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and…
On Sept. 8, 2020, researchers at Albert Einstein College of Medicine, led by Ana Maria Cuervo, M.D., Ph.D.,…
On Sept. 2, 2020, the National Institutes of Health (NIH) announced $129.3 million in scale-up and manufacturing support…
On Sept. 2, 2020, Novavax announced the publication in The New England Journal of Medicine of Phase 1…
On Sept. 2, 2020, Aegis Sciences announced that it had been selected to participate in the National Institutes…
On Sept. 1, 2020, the National Institutes of Health announced that it had launched a study to track…
On Sept. 1, 2020, HDT Bio received a notice of award from the National Institute of Allergy and…
On Aug. 31, 2020, An international team of scientists supported by the National Institute on Alcohol Abuse and…
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…
On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
On Aug. 23, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
On Aug. 18, 2020, the National Institutes of Health (NIH) awarded Albert Einstein College of Medicine and Montefiore…
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
On Aug. 14, 2020, research supported by the National Institutes of Health (NIH) delineated how two relatively common…
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
On Aug. 13, 2020, the National Institutes of Health (NIH) announced a new interactive mapping tool that showcases…
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
On Aug. 12, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to NS Pharma’s Viltepso…
On Aug. 9, 2020, Intravacc announced that it had been awarded a contract with base and options that…
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…
On Aug. 6, 2020, Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,…
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
On Aug. 5, 2020, a diagnostic test capable of accurately and reliably detecting the microorganism that causes gonorrhea…
On Aug. 5, 2020, a randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen…
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…